Singulair and Motegrity drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Singulair (montelukast sodium) and Motegrity (prucalopride succinate). Common drug interactions include constipation among females and dyspnoea among males.

The phase IV clinical study analyzes what interactions people have when they take Singulair and Motegrity. It is created by eHealthMe based on reports of 39 people who take the same drugs from the FDA, and is updated regularly.

What is Singulair?

Singulair has active ingredients of montelukast sodium. It is often used in asthma. eHealthMe is studying from 129,752 Singulair users. Check the latest studies of Singulair.

What is Motegrity?

Motegrity has active ingredients of prucalopride succinate. eHealthMe is studying from 1,380 Motegrity users. Check the latest studies of Motegrity.



On Aug, 02, 2026

39 people who take Singulair and Motegrity together, and have interactions are studied.

Singulair and Motegrity drug interactions.

What are the common drug interactions of Singulair and Motegrity, by gender? *:

female:

  1. Constipation
  2. Migraine (headache)
  3. Pruritus (severe itching of the skin)
  4. Urticaria (rash of round, red welts on the skin that itch intensely)
  5. Drug ineffective
  6. Suicidal ideation
  7. Anxiety
  8. Arthralgia (joint pain)
  9. Dehydration (dryness resulting from the removal of water)
  10. Hypertension (high blood pressure)

male:

  1. Dyspnoea (difficult or laboured respiration)
  2. Hemiplegia (paralysis of one side of the body)
  3. Hyperhidrosis (abnormally increased sweating)
  4. Sputum discoloured
  5. Swollen tongue (swelling of tongue)
  6. Urticaria (rash of round, red welts on the skin that itch intensely)

What are the common drug interactions of Singulair and Motegrity, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Foot fracture
  2. Hypoaesthesia (reduced sense of touch or sensation)
  3. Ligament sprain (ligament stretched)
  4. Lyme disease (a bacterial infection that is spread to humans by infected ticks)
  5. Neuroma (tumour of nerve tissue)
  6. Pain
  7. Pain in extremity
  8. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  9. Pruritus (severe itching of the skin)
  10. Urticaria (rash of round, red welts on the skin that itch intensely)

30-39:

  1. Age-related macular degeneration
  2. Anxiety
  3. Depression
  4. Fall
  5. Hand fracture
  6. Maculopathy (a condition or disease of the macula, the small spot in the retina where vision is keenest)
  7. Multiple injuries
  8. Retinal degeneration (death of the cells of the retina)
  9. Retinal tear
  10. Vitreous detachment (a condition of the eye in which the vitreous humour separates from the retina)

40-49:

  1. Headache (pain in head)
  2. Pruritus (severe itching of the skin)
  3. Urticaria (rash of round, red welts on the skin that itch intensely)
  4. Chest discomfort
  5. Cough
  6. Dyspnoea (difficult or laboured respiration)
  7. Rash

50-59:

  1. Alopecia (absence of hair from areas of the body)
  2. Drug ineffective
  3. Infection
  4. Anxiety
  5. Deafness
  6. Immunisation reaction
  7. Injection site swelling
  8. Stress
  9. Vertigo
  10. Hyperhidrosis (abnormally increased sweating)

60+:

  1. Muscle spasms (muscle contraction)
  2. Suicidal behaviour
  3. Suicidal ideation
  4. Tearfulness (excess tearing)
  5. Dyspnoea (difficult or laboured respiration)
  6. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  7. Pneumonia
  8. Sputum discoloured

What are the existing conditions these people have? *

  1. Immunodeficiency Common Variable: 5 people, 12.82%
  2. Constipation: 4 people, 10.26%
  3. Primary Immunodeficiency Syndrome: 3 people, 7.69%
  4. Dermatomyositis (inflammation of the skin and underlying muscle tissue, typically occurring as an autoimmune condition or associated with internal cancer): 3 people, 7.69%
  5. Pain: 2 people, 5.13%
  6. Nausea And Vomiting: 2 people, 5.13%
  7. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 2 people, 5.13%
  8. Migraine (headache): 2 people, 5.13%
  9. Irritable Bowel Syndrome: 2 people, 5.13%
  10. Immunodeficiency: 2 people, 5.13%

* Approximation only. Some reports may have incomplete information.

Do you take Singulair and Motegrity?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Singulair and Motegrity:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Singulair:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Motegrity:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Singulair and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Motegrity and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on montelukast sodium and prucalopride succinate (the active ingredients of Singulair and Motegrity, respectively), and Singulair and Motegrity (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: